TXG
10x Genomics Inc Earnings
$13.12
Earnings Summary
Revenue | $172.91Mn |
Net Profits | $34.54Mn |
Net Profit Margins | 19.97% |
10x Genomics Inc’s revenue jumped 12.93% since last year same period to $172.91Mn in the Q2 2025. On a quarterly growth basis, 10x Genomics Inc has generated 11.64% jump in its revenue since last 3-months.
10x Genomics Inc’s net profit jumped 191.14% since last year same period to $34.54Mn in the Q2 2025. On a quarterly growth basis, 10x Genomics Inc has generated 200.52% jump in its net profits since last 3-months.
10x Genomics Inc’s net profit margin jumped 180.7% since last year same period to 19.97% in the Q2 2025. On a quarterly growth basis, 10x Genomics Inc has generated 190.04% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.07 |
EPS Estimate Current Year | -0.07 |
10x Genomics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.07 - a 77.42% jump from last quarter’s estimates.
10x Genomics Inc’s earning per share (EPS) estimates for the current year stand at -0.07.
Key Ratios
Earning Per Share (EPS) | 0.28 |
10x Genomics Inc’s earning per share (EPS) jumped 187.5% since last year same period to 0.28 in the Q2 2025. This indicates that the 10x Genomics Inc has generated 187.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-09 | -0.47 | -0.28 | 40.43% |
2025-08-08 | -0.31 | 0.28 | 190.32% |
